Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes.

Bindoli S, Cadore C, Guidea I, Doria A, Ramonda R, Sfriso P.

Open source

DOI
10.1002/acr2.70106
Published
2025-10-01
Container
ACR Open Rheumatol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr2.70106,
  title = {Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes.},
  author = {Bindoli S and  Cadore C and  Guidea I and  Doria A and  Ramonda R and  Sfriso P.},
  year = {2025},
  journal = {ACR Open Rheumatol},
  doi = {10.1002/acr2.70106},
  url = {https://doi.org/10.1002/acr2.70106}
}

RIS

TY  - JOUR
TI  - Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes.
AU  - Bindoli S
AU  -  Cadore C
AU  -  Guidea I
AU  -  Doria A
AU  -  Ramonda R
AU  -  Sfriso P.
PY  - 2025
JO  - ACR Open Rheumatol
DO  - 10.1002/acr2.70106
UR  - https://doi.org/10.1002/acr2.70106
ER  - 

APA

S, B., C, C., I, G., A, D., R, R., & P., S. (2025). Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes.. ACR Open Rheumatol. https://doi.org/10.1002/acr2.70106

Source records